VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q39186985 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000106.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q39186985‏
024 ‎‡a 0000-0001-6614-569X‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q39186985‏
100 0 ‎‡a Matthew D Smith‏ ‎‡9 nl‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a ম্যাথু ডি স্মিথ‏ ‎‡c গবেষক‏ ‎‡9 bn‏
400 0 ‎‡a Matthew D Smith‏ ‎‡c researcher (ORCID 0000-0001-6614-569X)‏ ‎‡9 en‏
670 ‎‡a Author's A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis‏
670 ‎‡a Author's BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes‏
670 ‎‡a Author's Bryostatin-1 alleviates experimental multiple sclerosis.‏
670 ‎‡a Author's CNS-targeted autoimmunity leads to increased influenza mortality in mice.‏
670 ‎‡a Author's Dimethyl fumarate treatment alters NK cell function in multiple sclerosis‏
670 ‎‡a Author's Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes‏
670 ‎‡a Author's Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.‏
670 ‎‡a Author's Early complement genes are associated with visual system degeneration in multiple sclerosis‏
670 ‎‡a Author's Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis‏
670 ‎‡a Author's Glutamine antagonism attenuates physical and cognitive deficits in a model of MS‏
670 ‎‡a Author's Inducible deposition of the histone variant H3.3 in interferon-stimulated genes.‏
670 ‎‡a Author's Inhibition of neutral sphingomyelinase 2 promotes remyelination‏
670 ‎‡a Author's Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.‏
670 ‎‡a Author's Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis‏
670 ‎‡a Author's Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism‏
670 ‎‡a Author's NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity‏
670 ‎‡a Author's Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination‏
670 ‎‡a Author's PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)‏
670 ‎‡a Author's Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models‏
670 ‎‡a Author's Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis‏
670 ‎‡a Author's Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell Differentiation‏
670 ‎‡a Author's Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice‏
670 ‎‡a Author's Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement‏
909 ‎‡a (orcid) 000000016614569x‏ ‎‡9 1‏
919 ‎‡a dimethylfumaratetreatmentinduceslipidmetabolismalterationsthatarelinkedtoimmunologicalchanges‏ ‎‡A Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes‏ ‎‡9 1‏
919 ‎‡a disparateeffectsofmesenchymalstemcellsinexperimentalautoimmuneencephalomyelitisandcuprizoneinduceddemyelination‏ ‎‡A Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.‏ ‎‡9 1‏
919 ‎‡a earlycomplementgenesareassociatedwithvisualsystemdegenerationinmultiplesclerosis‏ ‎‡A Early complement genes are associated with visual system degeneration in multiple sclerosis‏ ‎‡9 1‏
919 ‎‡a glialpathologyandretinalneurotoxicityintheanteriorvisualpathwayinexperimentalautoimmuneencephalomyelitis‏ ‎‡A Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis‏ ‎‡9 1‏
919 ‎‡a glutamineantagonismattenuatesphysicalandcognitivedeficitsinamodelofms‏ ‎‡A Glutamine antagonism attenuates physical and cognitive deficits in a model of MS‏ ‎‡9 1‏
919 ‎‡a inducibledepositionofthehistonevarianth33ininterferonstimulatedgenes‏ ‎‡A Inducible deposition of the histone variant H3.3 in interferon-stimulated genes.‏ ‎‡9 1‏
919 ‎‡a inhibitionofneutralsphingomyelinase2promotesremyelination‏ ‎‡A Inhibition of neutral sphingomyelinase 2 promotes remyelination‏ ‎‡9 1‏
919 ‎‡a lymphocytemicrogliaastrocyteaxisinchronicactivemultiplesclerosis‏ ‎‡A A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis‏ ‎‡9 1‏
919 ‎‡a lineagetracingrevealsdynamicchangesinoligodendrocyteprecursorcellsfollowingcuprizoneinduceddemyelination‏ ‎‡A Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced demyelination.‏ ‎‡9 1‏
919 ‎‡a mesenchymalstemcellsdifferentiallymodulateeffectorcd8+tcellsubsetsandexacerbateexperimentalautoimmuneencephalomyelitis‏ ‎‡A Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis‏ ‎‡9 1‏
919 ‎‡a multiomicevaluationofmetabolicalterationsinmultiplesclerosisidentifiesshiftsinaromaticaminoacidmetabolism‏ ‎‡A Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism‏ ‎‡9 1‏
919 ‎‡a nlrx1inhibitstheearlystagesofcnsinflammationandpreventstheonsetofspontaneousautoimmunity‏ ‎‡A NLRX1 inhibits the early stages of CNS inflammation and prevents the onset of spontaneous autoimmunity‏ ‎‡9 1‏
919 ‎‡a oligodendrocyteprecursorcellspresentantigenandarecytotoxictargetsininflammatorydemyelination‏ ‎‡A Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination‏ ‎‡9 1‏
919 ‎‡a petimagingofmicrogliabytargetingmacrophagecolonystimulatingfactor1receptorcsf1r‏ ‎‡A PET imaging of microglia by targeting macrophage colony-stimulating factor 1 receptor (CSF1R)‏ ‎‡9 1‏
919 ‎‡a proteomicalterationsandnovelmarkersofneurotoxicreactiveastrocytesinhumaninducedpluripotentstemcellmodels‏ ‎‡A Proteomic Alterations and Novel Markers of Neurotoxic Reactive Astrocytes in Human Induced Pluripotent Stem Cell Models‏ ‎‡9 1‏
919 ‎‡a quetiapinehasanadditiveeffecttotriiodothyronineininducingdifferentiationofoligodendrocyteprecursorcellsthroughinductionofcholesterolbiosynthesis‏ ‎‡A Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis‏ ‎‡9 1‏
919 ‎‡a reactiveastrocytesderivedfromhumaninducedpluripotentstemcellssuppressoligodendrocyteprecursorcelldifferentiation‏ ‎‡A Reactive Astrocytes Derived From Human Induced Pluripotent Stem Cells Suppress Oligodendrocyte Precursor Cell Differentiation‏ ‎‡9 1‏
919 ‎‡a transferofmyelinreactiveth17cellsimpairsendogenousremyelinationinthecentralnervoussystemofcuprizonefedmice‏ ‎‡A Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice‏ ‎‡9 1‏
919 ‎‡a trialofintrathecalrituximabinprogressivemultiplesclerosispatientswithevidenceofleptomeningealcontrastenhancement‏ ‎‡A Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement‏ ‎‡9 1‏
919 ‎‡a brd4coordinatesrecruitmentofpausereleasefactorptefbandthepausingcomplexnelfdsiftoregulatetranscriptionelongationofinterferonstimulatedgenes‏ ‎‡A BRD4 coordinates recruitment of pause release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon-stimulated genes‏ ‎‡9 1‏
919 ‎‡a bryostatin1alleviatesexperimentalmultiplesclerosis‏ ‎‡A Bryostatin-1 alleviates experimental multiple sclerosis.‏ ‎‡9 1‏
919 ‎‡a cnstargetedautoimmunityleadstoincreasedinfluenzamortalityinmice‏ ‎‡A CNS-targeted autoimmunity leads to increased influenza mortality in mice.‏ ‎‡9 1‏
919 ‎‡a dimethylfumaratetreatmentaltersnkcellfunctioninmultiplesclerosis‏ ‎‡A Dimethyl fumarate treatment alters NK cell function in multiple sclerosis‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 DNB|1157933289
996 ‎‡2 RERO|A016603644
996 ‎‡2 LC|no2007049193
996 ‎‡2 LC|no2016122970
996 ‎‡2 DNB|1158581408
996 ‎‡2 LC|nr2006009016
996 ‎‡2 LC|no2005008518
996 ‎‡2 NTA|236553739
996 ‎‡2 ISNI|0000000109560213
996 ‎‡2 J9U|987007318561005171
996 ‎‡2 RERO|A016513627
996 ‎‡2 NKC|jcu20191056684
996 ‎‡2 ISNI|000000002567802X
996 ‎‡2 CAOONL|ncf11614859
996 ‎‡2 LC|n 98094547
996 ‎‡2 LC|n 2008051897
996 ‎‡2 LC|no2017015859
996 ‎‡2 ISNI|0000000050885530
996 ‎‡2 LC|n 92806495
996 ‎‡2 LC|no2011074228
996 ‎‡2 CAOONL|ncf11336378
996 ‎‡2 LC|n 82225400
996 ‎‡2 ISNI|0000000512430769
996 ‎‡2 LC|n 88080269
996 ‎‡2 LC|no2023007759
996 ‎‡2 DNB|1252504535
996 ‎‡2 BIBSYS|3029307
996 ‎‡2 LC|n 83163851
996 ‎‡2 LC|no2014082038
996 ‎‡2 ISNI|0000000425267836
996 ‎‡2 DNB|1057677523
996 ‎‡2 LC|n 87129323
996 ‎‡2 LC|no2011114116
996 ‎‡2 LC|n 90722268
996 ‎‡2 DNB|136979858
996 ‎‡2 SUDOC|126608539
996 ‎‡2 ISNI|0000000107585732
996 ‎‡2 ISNI|0000000118011945
996 ‎‡2 ISNI|0000000116920205
996 ‎‡2 NII|DA1409564X
996 ‎‡2 SZ|1297585232
996 ‎‡2 NKC|jo2014835388
996 ‎‡2 J9U|987007447422605171
996 ‎‡2 DNB|130633733X
996 ‎‡2 BIBSYS|1697004295867
996 ‎‡2 DNB|123436073X
996 ‎‡2 NTA|117771503
996 ‎‡2 W2Z|1615360583045
996 ‎‡2 JPG|500125718
996 ‎‡2 LC|n 2001129245
996 ‎‡2 DNB|124010210
996 ‎‡2 NTA|256581258
996 ‎‡2 BNE|XX5749585
996 ‎‡2 LC|no2008084982
996 ‎‡2 BIBSYS|1707990466700
996 ‎‡2 BNF|15108717
996 ‎‡2 J9U|987007427973905171
996 ‎‡2 LC|no2022081475
996 ‎‡2 LC|n 98033388
996 ‎‡2 LC|no2003095337
996 ‎‡2 BIBSYS|1054712
996 ‎‡2 LC|n 99053751
996 ‎‡2 NKC|xx0164138
996 ‎‡2 LC|n 77004568
996 ‎‡2 NII|DA17944850
996 ‎‡2 BIBSYS|12068531
996 ‎‡2 ISNI|0000000024659038
996 ‎‡2 CAOONL|ncf11397382
996 ‎‡2 J9U|987009828069805171
996 ‎‡2 DNB|107286794X
996 ‎‡2 LC|n 97856262
996 ‎‡2 J9U|987007272636405171
996 ‎‡2 NII|DA08912117
996 ‎‡2 LC|no2019006290
996 ‎‡2 BIBSYS|3040180
996 ‎‡2 LC|no 98128295
996 ‎‡2 ISNI|0000000512661380
996 ‎‡2 CAOONL|ncf11634188
996 ‎‡2 LC|n 50013283
996 ‎‡2 SUDOC|160193311
996 ‎‡2 SUDOC|225836750
996 ‎‡2 LC|no2010139855
996 ‎‡2 LC|nb2016013124
996 ‎‡2 BIBSYS|2055690
996 ‎‡2 SUDOC|202426432
996 ‎‡2 DNB|1155945433
996 ‎‡2 ISNI|0000000416668814
996 ‎‡2 BNCHL|10000000000000000113813
996 ‎‡2 J9U|987007436318905171
996 ‎‡2 JPG|500055674
996 ‎‡2 SUDOC|170626148
996 ‎‡2 BIBSYS|90862526
996 ‎‡2 LC|n 2015010393
996 ‎‡2 BNF|16564487
996 ‎‡2 NUKAT|n 2015140688
996 ‎‡2 NYNYRILM|69870
996 ‎‡2 ISNI|0000000433100913
996 ‎‡2 ISNI|0000000038654844
996 ‎‡2 LC|n 2008084201
996 ‎‡2 SUDOC|267461410
996 ‎‡2 LC|no2022127555
996 ‎‡2 NUKAT|n 2022200918
996 ‎‡2 DNB|173581595
996 ‎‡2 XA|10047
996 ‎‡2 LC|n 84233725
996 ‎‡2 PLWABN|9810637382705606
996 ‎‡2 LC|no2022081023
996 ‎‡2 DNB|1012584550
996 ‎‡2 LC|n 90722145
996 ‎‡2 DNB|103546568X
996 ‎‡2 ISNI|0000000401736036
996 ‎‡2 ISNI|0000000039214402
996 ‎‡2 J9U|987007426941805171
996 ‎‡2 BNF|15596998
996 ‎‡2 LC|n 84803734
996 ‎‡2 BIBSYS|90383626
996 ‎‡2 CAOONL|ncf10607110
996 ‎‡2 LC|n 90652327
996 ‎‡2 ISNI|0000000040052375
996 ‎‡2 RERO|A022958126
996 ‎‡2 LC|no2015099843
996 ‎‡2 NTA|338287000
996 ‎‡2 LC|no2018067960
996 ‎‡2 BIBSYS|10043450
996 ‎‡2 SUDOC|178156426
996 ‎‡2 ISNI|0000000063624073
996 ‎‡2 ISNI|0000000039448030
996 ‎‡2 LC|n 2007012830
996 ‎‡2 N6I|vtls000078681
996 ‎‡2 DNB|1297585232
996 ‎‡2 LC|nb2017006247
996 ‎‡2 BNE|XX5684882
996 ‎‡2 LC|no2002024081
996 ‎‡2 ISNI|0000000510924642
996 ‎‡2 LC|n 82047703
996 ‎‡2 NII|DA19617651
996 ‎‡2 LC|n 93118616
996 ‎‡2 LC|no2020134563
996 ‎‡2 CAOONL|ncf10647145
996 ‎‡2 PLWABN|9810809592305606
996 ‎‡2 LC|no 00046770
996 ‎‡2 CAOONL|ncf11440681
996 ‎‡2 LC|no2013034317
996 ‎‡2 LC|nr2001000897
996 ‎‡2 BNF|14137981
996 ‎‡2 NKC|jo20191025577
996 ‎‡2 LC|n 2001040616
996 ‎‡2 ISNI|0000000074331647
996 ‎‡2 BIBSYS|1101005
996 ‎‡2 LC|n 85352229
996 ‎‡2 LC|no2016040110
996 ‎‡2 JPG|500193401
996 ‎‡2 CAOONL|ncf11196667
996 ‎‡2 LC|no2019110764
996 ‎‡2 DNB|129502138
996 ‎‡2 ISNI|0000000499263627
996 ‎‡2 LC|nb2014011515
996 ‎‡2 DNB|1195739117
996 ‎‡2 LC|no 98004579
996 ‎‡2 RERO|A022796229
996 ‎‡2 PLWABN|9812480733705606
996 ‎‡2 DNB|115736957X
996 ‎‡2 LC|no2001092900
996 ‎‡2 LNB|LNC10-000156999
996 ‎‡2 DNB|126636062X
996 ‎‡2 DNB|1013765796
996 ‎‡2 LC|n 88238165
996 ‎‡2 BIBSYS|10020233
996 ‎‡2 ISNI|0000000085305364
996 ‎‡2 CAOONL|ncf11160211
996 ‎‡2 ISNI|0000000037108489
996 ‎‡2 ISNI|0000000403207453
996 ‎‡2 LC|nb2013003455
996 ‎‡2 LC|n 80046200
996 ‎‡2 ISNI|000000003384848X
996 ‎‡2 LC|no2024050529
996 ‎‡2 J9U|987007443612305171
996 ‎‡2 ISNI|0000000068377972
996 ‎‡2 LC|no2015044194
996 ‎‡2 LC|no 95052676
996 ‎‡2 LC|n 89121556
996 ‎‡2 J9U|987007318869905171
996 ‎‡2 LC|no2002055112
996 ‎‡2 ISNI|0000000048597126
996 ‎‡2 J9U|987007331006905171
996 ‎‡2 ISNI|0000000451223669
996 ‎‡2 ISNI|0000000046781405
996 ‎‡2 LC|n 79111477
996 ‎‡2 LC|n 2014035183
996 ‎‡2 NUKAT|n 2021080055
996 ‎‡2 NKC|utb20181000602
996 ‎‡2 ISNI|0000000038853384
996 ‎‡2 LC|nb2014011996
996 ‎‡2 LC|no2015003925
996 ‎‡2 J9U|987007404243905171
996 ‎‡2 LC|n 2013036016
996 ‎‡2 NSK|000221439
996 ‎‡2 LC|n 2018006555
996 ‎‡2 LC|n 2024031898
996 ‎‡2 JPG|500006663
996 ‎‡2 RERO|A026695646
996 ‎‡2 SUDOC|165584890
996 ‎‡2 NII|DA17552395
996 ‎‡2 SUDOC|066888034
996 ‎‡2 DNB|1270592718
996 ‎‡2 ISNI|000000003432395X
996 ‎‡2 ISNI|0000000114996222
996 ‎‡2 LC|no2011065660
996 ‎‡2 SUDOC|262160730
996 ‎‡2 CAOONL|ncf11328035
996 ‎‡2 LC|nb2021012873
996 ‎‡2 ISNI|0000000060706233
996 ‎‡2 LC|no2018093957
996 ‎‡2 ISNI|000000013878470X
996 ‎‡2 ISNI|000000004822838X
996 ‎‡2 ISNI|0000000077727284
996 ‎‡2 DNB|101611317X
996 ‎‡2 J9U|987007364768505171
996 ‎‡2 BIBSYS|2135589
996 ‎‡2 J9U|987007449519605171
996 ‎‡2 LC|no2015068882
996 ‎‡2 W2Z|1707990466700
996 ‎‡2 ISNI|0000000053535122
996 ‎‡2 ISNI|0000000028390208
996 ‎‡2 SUDOC|170529029
996 ‎‡2 DNB|1250925282
996 ‎‡2 ISNI|0000000119135851
996 ‎‡2 ISNI|000000002724206X
996 ‎‡2 ISNI|0000000138584345
996 ‎‡2 DNB|1180506596
996 ‎‡2 W2Z|1579001847029
996 ‎‡2 BNC|981058510888206706
996 ‎‡2 DNB|1210949121
996 ‎‡2 NTA|296637297
996 ‎‡2 ISNI|0000000097896253
996 ‎‡2 LC|no2021120206
996 ‎‡2 LC|no2013111666
996 ‎‡2 ISNI|0000000122571910
996 ‎‡2 LC|no2010150344
996 ‎‡2 DNB|1190385546
996 ‎‡2 J9U|987007406037805171
996 ‎‡2 ISNI|0000000054469390
996 ‎‡2 LC|n 2009053580
996 ‎‡2 LC|n 97021916
996 ‎‡2 LC|n 2010057986
996 ‎‡2 LC|nb2009017101
996 ‎‡2 LC|nb2009017100
996 ‎‡2 ISNI|0000000383816568
996 ‎‡2 SUDOC|169950514
996 ‎‡2 RERO|A023068041
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏